线粒体功能障碍作为HFpEF的治疗关联:治疗目标和药理学进展
Tian Yue1, Dezhi Zheng2, Jian He1
1Department of Cardiology, The Third People's Hospital of Chengdu/Affiliated Hospital of Southwest Jiaotong University, Chengdu Institute of Cardiovascular Disease, Chengdu, Sichuan, China.
Frontiers in pharmacology
|October 15, 2025
概括
保存喷射分数 (HFpEF) 的心力衰竭涉及线粒体功能障碍,影响能量代谢并导致不良结果. 准线粒体为这种情况提供了一个有前途的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
- 病理生理学 病理生理学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭影响50%的心力衰竭病例,因衰老和代谢疾病的发病率上升.
- HFpEF缺乏有效的治疗方法,其5年死亡率为50%,与心力衰竭减少射出小部分 (HFrEF) 不同.
- 线粒体功能障碍是HFpEF中将代谢障碍与心脏功能受损联系起来的关键机制.
研究的目的:
- 系统地审查HFpEF的分子机制,重点关注线粒体功能障碍.
- 为了全面评估针对线粒体功能的药物,用于HFpEF治疗.
- 探索HFpEF新兴的线粒体向疗法.
主要方法:
- 在HFpEF中的分子机制的文献综述.
- 对影响线粒体功能的已销售和正在研究药物的分析.
- 探索针对线粒体的新型治疗策略.
主要成果:
- 高FpEF涉及线粒体能量代谢障碍,动态失衡,氧化应激和失调.
- 在HFpEF中审查了改善线粒体功能的药物的证据.
- 确定了针对HFpEF中线粒体功能障碍的新兴策略.
结论:
- 线粒体功能障碍是HFpEF的关键病理生理机制和治疗点.
- 准线粒体有可能改善HFpEF预后.
- 本综述提供了HFpEF研究,药物开发和精密治疗的参考.
更多相关视频
相关概念视频
Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K
Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Heart Failure I: Introduction
693
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
693


